Wadden Thomas A, West Delia S, Neiberg Rebecca H, Wing Rena R, Ryan Donna H, Johnson Karen C, Foreyt John P, Hill James O, Trence Dace L, Vitolins Mara Z
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Obesity (Silver Spring). 2009 Apr;17(4):713-22. doi: 10.1038/oby.2008.637. Epub 2009 Jan 29.
This report provides a further analysis of the first year weight losses in the Look AHEAD (Action for Health in Diabetes) study and identifies factors associated with success. Participants were a total of 5,145 men and women with type 2 diabetes who were recruited at 16 sites and randomly assigned to an intensive lifestyle intervention (ILI) or a control condition, Diabetes Support and Education (DSE). During year 1, participants in ILI received comprehensive diet and physical activity counseling in a total of 42 group and individual sessions, compared with three educational sessions for DSE participants. As reported previously, at the end of the year, ILI participants lost 8.6% of initial weight, compared to 0.7% for DSE (P < 0.001). Within the ILI group, all racial/ethnic groups achieved clinically significant weight losses (>5.5%), although there were significant differences among groups. For the year, ILI participants attended an average of 35.4 treatment sessions and reported exercising a mean of 136.6 min/week and consuming a total of 360.9 meal replacement products. Greater self-reported physical activity was the strongest correlate of weight loss, followed by treatment attendance and consumption of meal replacements. The use of orlistat, during the second half of the year, increased weight loss only marginally in those ILI participants who had lost <5% of initial weight during the first 6 months and chose to take the medication thereafter as a toolbox option. The lifestyle intervention was clinically effective in all subsets of an ethnically and demographically diverse population.
本报告对“展望未来(糖尿病健康行动)”研究中第一年的体重减轻情况进行了进一步分析,并确定了与成功相关的因素。参与者共有5145名2型糖尿病男性和女性,他们在16个地点招募,并随机分配到强化生活方式干预组(ILI)或对照组糖尿病支持与教育组(DSE)。在第1年期间,ILI组的参与者总共接受了42次小组和个人的综合饮食和身体活动咨询,而DSE组的参与者接受了3次教育课程。如先前报道,到年底时,ILI组的参与者体重减轻了初始体重的8.6%,而DSE组为0.7%(P<0.001)。在ILI组中,所有种族/族裔群体都实现了临床上显著的体重减轻(>5.5%),尽管各群体之间存在显著差异。这一年中,ILI组的参与者平均参加了35.4次治疗课程,报告平均每周锻炼136.6分钟,共食用了360.9份代餐产品。自我报告的运动量越大,与体重减轻的相关性越强,其次是治疗课程的参与度和代餐产品的食用量。在下半年,对于那些在前6个月体重减轻<初始体重5%且此后选择服用该药物作为一种手段的ILI组参与者,使用奥利司他仅使体重减轻略有增加。这种生活方式干预在一个种族和人口统计学上多样化的人群的所有亚组中都具有临床效果。